Literature DB >> 23917307

Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey.

J H Kim1, Y-S Ha, S J Jeong, S Kim, W-J Kim, T L Jang, I Y Kim.   

Abstract

BACKGROUND: Few studies have analyzed factors that influence longitudinal changes in patient-perceived satisfaction during the recovery period following robot-assisted radical prostatectomy (RARP) for prostate cancer. We investigated variables that were associated with patient-perceived satisfaction after RARP using the expanded prostate cancer index composite (EPIC) survey.
METHODS: Of 175 men who underwent RARP between 2010 and 2011, 140 men completed the EPIC questionnaire preoperatively and 3, 6 and 12 months postoperatively. On the basis of the EPIC question no. 32 (item number 80), patients were divided into four groups according to the pattern of satisfaction change at postoperative 3 and 12 months: satisfied to satisfied (group 1); satisfied to dissatisfied (group 2); dissatisfied to satisfied (group 3); and dissatisfied to dissatisfied (group 4). Longitudinal changes in EPIC scores over time in each group and differences in EPIC scores of each domain subscale between groups at each follow-up were analyzed. A linear mixed model with generalized estimating equation approach was used to identify independent factors that influence overall satisfaction among repeated measures from same patients.
RESULTS: On the basis of the pattern of satisfaction change, groups 1, 2, 3 and 4 had 103 (74.3%), 21 (15.0%), 11 (7.9%) and 5 (2.9%) patients, respectively. The factor that was associated with overall satisfaction was urinary bother (UB) (β=0.283, 95% confidence interval (0.024, 0.543 ); P=0.033) adjusted for other factors under consideration.
CONCLUSIONS: UB was the independent factor influencing patient-perceived satisfaction after RARP. During post-RARP follow-up, physician should have the optimal management for the patient's UB.

Entities:  

Mesh:

Year:  2013        PMID: 23917307      PMCID: PMC5767467          DOI: 10.1038/pcan.2013.24

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  24 in total

1.  Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Authors:  Montserrat Ferrer; José Francisco Suárez; Ferran Guedea; Pablo Fernández; Víctor Macías; Alfonso Mariño; Asunción Hervas; Ismael Herruzo; María José Ortiz; Humberto Villavicencio; Jordi Craven-Bratle; Olatz Garin; Ferran Aguiló
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-05       Impact factor: 7.038

2.  Direct comparison of surgical and functional outcomes of robotic-assisted versus pure laparoscopic radical prostatectomy: single-surgeon experience.

Authors:  A Ari Hakimi; Jeffrey Blitstein; Marc Feder; Edan Shapiro; Reza Ghavamian
Journal:  Urology       Date:  2008-10-26       Impact factor: 2.649

3.  Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

Authors:  Steven B Zeliadt; Scott D Ramsey; David F Penson; Ingrid J Hall; Donatus U Ekwueme; Leonard Stroud; Judith W Lee
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

4.  Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.

Authors:  J B Madalinska; M L Essink-Bot; H J de Koning; W J Kirkels; P J van der Maas; F H Schröder
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy.

Authors:  Vipul R Patel; Ananthakrishnan Sivaraman; Rafael F Coelho; Sanket Chauhan; Kenneth J Palmer; Marcelo A Orvieto; Ignacio Camacho; Geoff Coughlin; Bernardo Rocco
Journal:  Eur Urol       Date:  2011-01-25       Impact factor: 20.096

6.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium.

Authors:  J Altwein; P Ekman; M Barry; C Biermann; P Carlsson; S Fosså; G Kiebert; T Küchler; D McLeod; A Porter; G Steineck
Journal:  Urology       Date:  1997-04       Impact factor: 2.649

8.  Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment.

Authors:  Michael A Diefenbach; Nihal E Mohamed
Journal:  Cancer Invest       Date:  2007-09       Impact factor: 2.176

9.  Baseline functional status may predict decisional regret following robotic prostatectomy.

Authors:  Hugh J Lavery; Adam W Levinson; Adele R Hobbs; Dov Sebrow; Nihal E Mohamed; Michael A Diefenbach; David B Samadi
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450

10.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Authors:  M S Litwin; R D Hays; A Fink; P A Ganz; B Leake; R H Brook
Journal:  Med Care       Date:  1998-07       Impact factor: 2.983

View more
  3 in total

Review 1.  Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-07

2.  Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study.

Authors:  Myung Soo Kim; Seung Il Jung; Ho Seok Chung; Eu Chang Hwang; Dongdeuk Kwon
Journal:  Prostate Int       Date:  2020-11-20

3.  Changes in health-related quality of life after radical prostatectomy for prostate cancer: A longitudinal cohort study in Korea.

Authors:  Sahyun Pak; Myong Kim; Hanjong Ahn
Journal:  Investig Clin Urol       Date:  2018-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.